In the present study, the electret 5-fluorouracil patch was developed, the effective surface potential, piezoelectric coefficient d 33 , open-circuit thermally stimulated discharge (TSD) current spectra and shear adhesion of the patch were measured. The drug release profile of the patch was determined by using high performance liquid chromatography method. A stable potential difference which was positively dependent on the surface potential of the electret was generated on two sides of the patch. The measurements of d 33 coefficient, TSD current spectra and adhesion performance showed that the electrostatic field of the electret could cause polarization and cohesive strength decreasing of the matrix molecules, change the distribution and interaction of the drug molecules in patch, therefore to increase the release of drug from the transdermal patch.
Introduction
A hypertrophic scar (HS) is a common consequence after surgery, wounds and burns. To reduce HSs, several approaches have been used, such as surgical excision, compression therapy, laser and light therapies, magnetic or electric field therapy, intralesional injection of some medicines [1] [2] [3] . However, the effect of single therapy is limited. Therefore, the combination of several approaches to inhibit the growth of HS and repair the scar tissue has been the research focus in fields of clinical medicine, biomedical engineering, tissue engineering and electrostatics.
5-fluorouracil (5-FU), a pyrimidine analog, is effective in treatment of HSs [4, 5] . It suppresses the inflammation response of the wound surface, induces the cell apoptosis and inhibits production of collagen to treat HS by intralesional injection. However, local injection of 5-FU may cause pain, pigmentation, ulceration etc on injection site, or some other side effects due to its strong biotoxicity [6] . Therefore, it is necessary to develop a safe administration system with higher 5-FU concentration in scar tissue.
Electret transdermal drug delivery system is based on the electrostatic field produced by electret to enhance drug permeation into and through the skin in controlled rate. Our previous studies indicated that electret could not only effectively increase the residual amount of lidocaine, meloxicam, cyclosporine A and insulin, etc in skin tissue, but control the drug release amount from the transdermal drug delivery system [7] [8] [9] [10] . In this study, we prepared a series of electret 5-FU transdermal patches. We aimed to investigate the piezoelectric coefficient d 33 , open-circuit thermally stimulated discharge (TSD) current spectra, shear adhesion and in vitro drug release profile of the patches, to study the influence of electret in drug distribution in transdermal patch and drug release behavior from the patch. Therefore, we can understand the efficacy of the electret 5-FU transdermal drug delivery system in HS treatment (the results will be published in another paper).
Materials and methods

Electret
The polypropylene (PP) films (Toray Industry Co., Japan) with a thickness of 13 μm were used to prepare the electret. The film was charged in a plasma charging system at atmospheric temperature for 5 min. The point voltage was set as 15 kV. The grid voltages were ±500 V, ±1000 V and ±2000 V, respectively. Electret surface potential was measured by compensation method using a surface potentiometer (ESR102A, Beijing Huajinghui Technology Co. Ltd, China).
Preparation of transdermal patches
2.2.1. 5-FU patch. The solution of 0.25 g Eudragit 100 (pressure sensitive adhesive, PSA) and 50% of tributyl citrate (plasticizer, w/w of total polymer) in ethanol was prepared and ultrasonicated for 20 min. Then 10 mg of 5-FU was dissolved in the above solution using ultrasonic bath to get a homogeneous solution. The solution thus prepared was then cast onto the PP backing layer in size of 5 cm×5 cm. The solvent was allowed to evaporate at room temperature for 12 h to yield the desired drug-in-adhesive film. Then the release liner was applied to the surface of the adhesive layer to obtain the 5-FU transdermal patch.
Electret 5-FU patch.
Electret 5-FU patches were prepared in a way that the charged surface of the electret with the surface potential of 500 V, −500 V, 1000 V, −1000 V, 2000 V or −2000 V was covered on the adhesive-free backing layer of 5-FU patch, respectively. The effective potential on surface of drug adhesive layer of the electret 5-FU patches was determined using a surface potentiometer.
TSD current spectra measurement
Electret or electret 5-FU patch with different polarity and surface potential was placed in a furnace (T5042K, Heraeus, Germany) and was heated at a uniform rate of 3°C min The piezoelectric coefficient d 33 was measured using a quasistatic d 33 meter (ZJ-3A, Chinese Academy of Science Institute of Acoustics, China).
Adhesion performance
The shear adhesion test was performed using a laboratorymade tester following the national standard technique [11] .
The patch was applied to a stainless steel plate. A specified weight was suspended from the patch in a direction parallel to the plate. The time taken to pull the patch from the plate was recorded as the shear adhesion. The measurements were performed in triplicate.
Drug release study
The improved Franz diffusion cells with a receptor compartment capacity of 7 ml and effective diffusion area of 3.14 cm 2 were used for release study. The receptor compartment was filled with phosphate buffer solution (PBS) with pH of 7.4 at 32°C and stirred at 500 rpm using a magnetic stirrer. The patch in circular was attached to a Cellophane ® membrane and then mounted between the donor and receptor compartments of the Franz cell. One ml samples were withdrawn from the receptor phase at 2, 4, 8, 12, 24 and 36 h and replaced with the same volume of fresh PBS in order to maintain sink condition.
The sample was assayed using high performance liquid chromatography with a Shimadzu instrument (LC-2010) and Diamonsil C18 column (5 μm, 250 mm×4.6 mm, Dikma Company). The mobile phase was a mixture of methanol and buffer (with water, 0.15% acetic acid, and 0.15% ethanolamine) solution (5:95, V/V) with a flow rate of 1 ml min −1 . The analysis wavelength was 265 nm. 10 μl of each sample was injected for analysis.
Statistical analysis
Data was analyzed by one-way analysis of variance followed by t-test using SPSS21.0 software. The significance level P was set at 0.05.
Results and discussion
Charge storage stability of electret
The effect of electret on enhancement of drug permeation through skin depends on its charge storage stability. Therefore, the normalized surface potential of electret was plotted against time (figure 1). A better charge storage stability for electret studied was observed. The surface potentials for 500 V and −500 V electrets were 433 V and −411 V respectively up to 168 h keeping at atmospheric temperature. Although 2000 and −2000 V electrets showed faster decrease of surface potentials compared with those of 500 and −500 V electrets, they could still keep 67.1% and 67.3% of their initial surface potentials at 168 h. It could be concluded that both the positive and negative electrets had the similar charge storage stability. The electret with higher initial surface potential could generate stronger external electrostatic field.
Charge characteristics of backing layer of electret 5-FU patch
To explore the influence of external electric field of electret in charge characteristics of backing layer of 5-FU patch, PP film was covered on the charged surface of the electret. The PP surface touching the charged face of electret was set as surface A, while the other side was surface B. The covering PP film was taken off 30 min later. And then the value and polarity of surface potential on surface A and B were measured. The polarity of surface A of the covering film was the same as that of the charged surface of electret, but the surface potential was obviously smaller than the electret (figure 2). The surface potentials for surface A touched to 2000 V and −2000 V electrets, for example, were 322 V and −368 V, respectively. The surface potential for surface B of the covering film was slightly smaller than that of the surface A, but with opposite polarity (figure 3). The results, on one hand, were associated with the detrapping of some surface charges of electret to form free charges due to the attachment of charged surface of electret with PP covering film. On the other hand, an extremely thin layer of air between the charged surface of electret and surface A of covering film was existed. The external electric field produced by electret might result in ionization of the air to positive and negative ions. The detrapped charges and ions with the same polarity as that of the electret, driven by the electric field of the electret, would move towards and injected to surface A of covering film, forming a charged layer that had the same polarity as the electret on surface A and exhibiting a slightly higher value of surface potential for negatively charged layer than that of the positive one. Because of the low concentration of detrapped charge and ionized ions, the surface potential of covering film was low. In addition, electrostatic induction caused opposite polarity of image charge (or induced charge) of surface B from surface A. And the value of surface potential of surface B is slightly lower than that of surface A.
To further characterize the charge property of the covering film, the TSD current spectrum of PP film was measured after it was covered on 2000 V electret for 8 h. In figure 4 , a single upward discharge current peak at 115°C was observed, suggesting that PP covering film became an excellent electret through plasma charging under the action of external electric field of 2000 V electret with surface A storing positive charges and surface B storing negative image charges. The result of TSD measurement was consistent with that of obtained from figure 3. 3.3. The stability of internal field of electret 5-FU patch Figure 5 shows the internal field or potential difference (=surface potential of electret-surface potential on adhesive drug layer of the electret drug patch) of different electret 5-FU patches as a function of time. The potential difference for all patches increased with time, but tended to be stable at 36 h. The electret patch with higher surface potential exhibited stronger internal field, because the matrix Eudragit E100 of the patch was a cationic copolymer which had a better adhesive performance. The external electrostatic field of electret could not only cause the weak polarization of matrix molecules, lead to the orientation polarization of the matrix molecules along the external field, but cause directional migration of drug molecules under the action of electric field. The electret with higher surface potential could produce stronger external electric field, leading to more obvious polarization and migration effects of the molecules in 5-FU patches and then stronger internal field of the patch. Therefore, the stable and higher internal field of the electret 5-FU patch could affect the drug distribution in patch.
Dielectric properties of electret 5-FU patches
Some materials may change their electric polarization when a mechanical stress is applied. Conversely, a realignment of the internal dipole structure or deformation in shape is produced in response to applied electric field. This effect is called piezoelectric effect and can be quantified by piezoelectric coefficient d xy . The higher d xy coefficient refers to better piezoelectric effect. d 33 coefficient is the primary piezoelectric effect which relates the strain developed in the direction of poling to the electric field applied in the same direction [12] . To understand the influence of electrostatic field in drug distribution in 5-FU patch, the d 33 coefficient and TSD current spectra were measured. Figures 6 and 7 show the d 33 coefficient as a function of time for PSA matrix patch and 5-FU patch under the action of electret. The d 33 value of 0 pC/N was observed for non-electret acted PSA matrix patch and 5-FU patch, suggesting a uniform distribution of molecules in matrix and patch. Then the d 33 value of PSA matrix patch increased exponentially and tended to be stable at 24 h after electret application. The electret with higher value of surface potential could result in higher d 33 value of the matrix patch because the polarization of matrix molecules positively depended on the external electric field of the electrets, but opposite polarized direction was exhibited after the action of positive or negative electret. Besides, the intermolecular force among the matrix molecules inhibited the orientation of molecules to some extent under the action of electrostatic field due to the stronger adhesion performance of matrix. A relative equilibrium between molecular force and electrostatic force was reached after 24 hours' action of electrets, a stable d 33 value being observed. The change of d 33 value with time for 5-FU patch under the action of electret was similar to that of the matrix patch, but only an obvious increase of d 33 value with electric field was observed compared with that of the matrix patch. The d 33 values for −2000 V and 2000 V electrets acted 5-FU patches were respectively 1.13 pC/N and −1.17 pC/N, being 18.8 times and 16.7 times those of the electret acted matrix patches. The change of drug distribution in patch caused by orientation migration of the molecules under the action of electric field of the electret resulted in relative accumulation of negative ions in local area of the patch and then an obvious increase of the d 33 value. Furthermore, the redistribution of drug molecules mainly counted for the change of dielectric property of electret 5-FU patch. Figure 8 shows the TSD spectra of matrix patch and 5-FU patch. The lacking of obvious discharge peak confirmed our previous conclusion that molecules in both the matrix and drug patches were distributed uniformly. However, the action of 1000 and −1000 V electrets on either patch for 72 h resulted in obvious discharge peaks in TSD spectra at about 135°C ( figure 9 ). About 20°C increase of peak temperature in figure 9 as compared with the peak at 115°C in figure 4 for PP film was observed. Under the action of external electric field of the electrets, large quantities of ions were injected into the backing layer of both the patches and then they were captured by different energy traps. During the process of TSD measurement, the captured ions began to detrap with heating, which resulting in decreased internal electric field of the patch, and accordingly disorientation of matrix molecules and directional migration (redistribution) of drug molecules. Due to the shear adhesion of the patch, it took time for molecules to disorientate and redistribute. Therefore, the TSD current peaks shifted to higher temperature for both of the patches. The inverse peak with some increased peak values for both patches acted by negative electret was related to (1) the opposite polarizing direction of matrix molecules and migration direction of drug molecules to that of the positive electric field; (2) more anionic drug molecules being clustered to the near surface which increased the effective surface charge density of the patches, and therefore larger peak value and peak area being observed in TSD spectra for negative electret acted patches. Thus, external electric field of electret could regulate the drug distribution in patch.
Shear adhesion of electret 5-FU patch
The adhesion performance of drug-adhesive patch is critical to drug delivery and therapeutic effect [13, 14] . Shear adhesion is a measure of cohesive strength of the adhesive. Higher cohesive strength resulted in lower release rate of drug from the patch [14] . It was noticed that the application of electret could decrease the shear adhesion of 5-FU patch, which was positively dependent upon the magnitude of electret surface potential but not the polarity of electret (figure 10). The external electric field of electret gave rise to the polarization of matrix molecules in patch, which changed the space structure and intermolecular force of E100 molecules, and then cause the reduction of cohesive strength of molecules in 5-FU patch. As discussed above, the polarization of molecules in patch was dependent upon the magnitude of the surface potential of electret. Thus, lower shear resistance was observed when electret with higher surface potential was applied to the patch.
Drug release study of electret 5-FU patch
The release profiles of 5-FU from different electret drug patches were shown in figure 11 . From the result it could be seen that ±1000 V electrets and ±2000 V electrets effectively enhance the release of 5-FU from the drug patch compared with that of 5-FU patch. The cumulative release amount (Q) increased with the surface potential of electrets. The negative electret had more enhancing effect than the positive electret. The Q values for −1000 V, 1000 V, −2000 V and 2000 V applied 5-FU patches were 1.24, 1.18, 1.40 and 1.31 times that of the 5-FU patch.
The drug release usually satisfies the Higuchi equation. For 5-FU patch, the releasing behavior could be described using the following equation 
where Q and t are cumulative release amount and time, respectively. The cumulative release amount of drug from the patch after application of electret was determined by the surface potential and polarity of the electret:
where V and t are surface potential and time, respectively.
As it is discussed above, the polarization of matrix molecules and change of distribution of drug molecules in patch under the action of external electric field of electrets, as well as the decrease of cohesive strength of the matrix and migration resistance of drug molecules in patch accounted for 
the enhancing release amount of 5-FU from the patch. Stronger external electric field generated by electret with higher surface potential resulted in more rapid migration rate of drug molecules and then larger release amount. Therefore, the controlled delivery and release of drug could be realized by adjusting the polarity and surface potential of electrets.
Conclusions
External electric field of electrets could cause the polarization of matrix molecules and redistribution of drug molecules in patch. They were confirmed by the dielectric property studies. Obviously increased d 33 values were observed after application of electrets to matrix patch and 5-FU patch. The TSD spectra of electret 5-FU patch showed obvious discharge current peak. The decreased shear adhesion of electret drug patch also confirmed the effect of external electric field of electret on polarization of matrix molecules. The higher was magnitude of the surface potential of electret, the larger effect was electrets on polarization of matrix molecules and drug molecules. Thus, rapid drug release from the patch was observed for electret patches with higher surface potential.
